Please find herewith the outcome of Board Meeting held on May 23, 2026
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bliss GVS Pharma's board noted a Share Purchase Agreement dated May 23, 2026 where Anupam Rasayan India Limited will acquire 4,58,03,024 shares (43.30%) from existing shareholders for ₹1,369.51 crore at ₹299 per share. The promoter group sellers (Mr. Narsimha Kamath, Dr. Vibha Sharma, Ms. Shruti Rao) are selling 31.59% stake while public shareholders are selling 11.70%. Three sellers may retain some balance shares (totaling 4.90%) with optional future sale to the Purchaser. The transaction will result in change of control as Anupam Rasayan will become the new promoter. This triggers a mandatory open offer under SEBI Takeover Regulations for up to 26% of the company.
This is a major change of control transaction that will completely transform the company's promoter group. Existing promoters are exiting almost entirely (31.59% stake sold), with Anupam Rasayan India Limited becoming the new controlling shareholder. The mandatory open offer for 26% will provide liquidity to public shareholders at an implied price of ₹299 per share.